Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.44 -0.03 (-0.86%)
At close: Oct 2, 2026 · 4:00 PM EDT

Insight Molecular Diagnostics (IMDX) Sales of Property, Plant and Equipment (2023)

Updated

Insight Molecular Diagnostics' Sales of Property, Plant and Equipment came in at $4,000 for FY2024, down 98.9% from $354,000 in FY2023.

Analysis

Insight Molecular Diagnostics (IMDX) Sales of Property, Plant and Equipment (2023) Analysis & Trends

  • Per Business Quant, earlier years put Sales of Property, Plant and Equipment at $354,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 4.00 Mn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn -
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn -
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn -
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn -
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn -
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn -
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn -
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn -
10 Insight Molecular Diagnostics 112.22 Mn 35.94 Mn 157,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 231,000.00
API Access

Insight Molecular Diagnostics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=IMDX&period=max&api_key=YOUR_API_KEY